Jun 3, 2024, 12:44
Yakup Ergün: Adding LCT does not improve survival in oligometastatic NSCLC
Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X:
“NRG-LU002: maintenance systemic therapy vs local consolidative therapy plus maintenance therapy in oligometastatic NSCLC.
90% having received IO-based therapy.
Adding LCT does not improve survival. It increases side effects.
Presented by Dr. Puneeth Iyengar.”
Source: Yakup Ergün/X